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Protein kinase R (PKR) and RNase L are host cell components that function to contain viral spread after infections. In this study,
we analyzed the role of both proteins in the abortive infection of humanHeLa cells with the poxvirus strain NYVAC, for which
an inhibition of viral A27L and B5R gene expression is described. Specifically, the translation of these viral genes is independent
of PKR activation, but their expression is dependent on the RNase L activity.
NYVAC is a vaccinia virus (VACV) strain that is replicationincompetent inmost human cells and is currently being used
as a recombinant poxvirus vaccine vector againstmultiple diseases
(for a review, see reference 1). One of the advantages of replica-
tion-deficient viruses is their safety profile, which makes them
excellent vehicles for vaccination purposes. However, it has been
postulated that the efficacy of replication-incompetent viruses,
like NYVAC, is limited by their failure to replicate and the conse-
quent limitation in antigen accumulation during virus infection
(1). It has been described that during the course of NYVAC infec-
tion in humanHeLa cells, there is a late translational blockage that
correlates with a marked increase in apoptosis (2, 3). An increase
in the phosphorylation status of the translation initiation factor
eIF2 (the subunit of eukaryotic initiation factor 2) is associated
with this inhibition of protein synthesis during NYVAC infection.
In particular, late viral proteins such as those encoded by A27L
(A27 protein), A17L (A17 protein), B5R (B5 protein), and L1R (L1
protein) genes are not detected in HeLa cells infected with NYVAC,
while other non-late viral proteins, such as those encoded byE3L (E3
protein) or A4L (A4 protein) or the early and late A36R (A36
protein) open reading frames (ORFs) are synthesized (2, 3). To
understand what leads to the lack of these proteins, we have ana-
lyzed which step in the viral life cycle is blocked in NYVAC-in-
fected HeLa cells. We compared viral protein synthesis in HeLa
cells infected with either NYVAC or the replication-competent
WR VACV strain, using Western blot analysis with specific anti-
bodies for some early (E3 and A36) and late (B5 and A27) viral
proteins. As shown in Fig. 1A, the early proteins E3 and A36 were
detected in both WR- and NYVAC-infected cells, and their ex-
pression was maintained throughout the infection. In contrast,
the late proteins B5 and A27 were only detected in WR-infected
HeLa cells, indicating a block in their expression during NYVAC
infection. The levels of early viral proteins were quite similar with
both viruses at 2 h postinfection (hpi), but with longer times post-
inection, the levels of E3 and A36 were diminished in NYVAC-
infected cells due to the severe blockage in protein translation due
to phosphorylation of the initiation factor eIF2, as previously
published (2, 3). These results were confirmed by immunofluo-
rescence analysis (data not shown) and are consistent with previ-
ous results obtained in human dendritic cells (DCs) and macro-
phages infected with NYVAC, in which the late proteins A17 and
A27 were not detected in infected cell lysates (4, 5).
Some VACV viral proteins, such as B5, are involved in virion
formation, in particular in the intracellular enveloped virus (IEV)
assembly and subsequent actin tail formation, which helps to en-
hance virus dissemination and pathogenesis (6–10). The mecha-
nism of VACV actin tail formation has been intensively investi-
gated with different VACV viruses (11), but not with NYVAC.
Although the A33 and A36 transmembrane proteins are both re-
quired for actin tail formation, only A36 has been shown to have a
direct role in this process (9–12). A36R is highly conserved in
Orthopoxvirus genomes, suggesting that virus-induced actin po-
lymerization at the plasma membrane is widely used by mamma-
lian poxviruses to enhance their cell-to-cell spread (11). Deletion
of the A36R gene and loss of A36 expression does not affect IEV
assembly, but they do lead to an absence of actin tail formation
and a small plaque size phenotype, indicative of a defect in viral
spread (9, 10, 13). The phosphorylation of Tyr112 and Tyr132 in
A36 by Src and Abl family kinases results in the recruitment of the
adaptor proteins Nck, WIP, N-WASP, and Grb2, which in turn
leads to activation of the Arp2/3 complex and the nucleation of
actin polymerization (11, 12, 14). Mutations of Tyr112 and
Tyr132 result in a loss of actin tail formation and in a reduction in
plaque size (15). It has also been shown that the A36 protein in-
teracts with A33 and that this interaction is required for the incor-
poration of the former into IEV membranes (16).
To study the effect of the absence of B5 viral late protein ex-
pression after NYVAC infection, we examined actin tail forma-
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tion, as the presence of B5 is a requirement for IEV production.
HeLa cells were infectedwithWRorNYVAC (5PFU/cell), and the
actin cytoskeleton was visualized by phalloidin staining at 24 hpi.
WR-infected cells had characteristic actin tails (Fig. 1B). In con-
trast, no actin tails were detected in NYVAC-infected cells. As the
tyrosine phosphorylation (P-Tyr) of A36mediated by Src and Abl
family kinases is essential for the nucleation of actin polymeriza-
tion, we analyzed the A36 phosphorylation levels after infection
with WR and NYVAC. We also examined the presence of A33,
since both proteins are necessary for the production of actin tails.
Cellular extracts ofHeLa cells infectedwithNYVAC,MVA, orWR
strains (5 PFU/cell) at 10 hpi were collected using a buffer con-
taining 1 mM sodium orthovanadate and were analyzed byWest-
ern blotting using the 4G10 anti-P-Tyr monoclonal antibody to
detect tyrosine-phosphorylated A36. Additionally, A33 expres-
sion was also determined by Western blotting. As shown in Fig.
1C, phosphorylation of A36was not observed inNYVAC-infected
cells, and it is noteworthy that the early A33 protein was also not
detected. Together, these results demonstrate that duringNYVAC
infection in HeLa cells, several viral proteins (A33 [Fig. 1C] and
A27 and B5 [Fig. 1A]) are not produced.While A36 is produced, it
is not phosphorylated. To study if the absence of B5 after NYVAC
infection is due to a mutation in its viral gene or to the restriction
by a cellular host range gene, we analyzed the levels of B5 protein
following coinfection of HeLa cells with NYVAC and the WR
VVB5R deletion mutant of VACV, which lacks the B5R gene.
HeLa cells were infected with a total of 5 PFU/cell of NYVAC and
VVB5R, and at the indicated times postinfection, B5 protein
expressionwas analyzed byWestern blotting. As shown in Fig. 2A,
B5 was detected at 16 h postcoinfection, indicating that the B5R
gene from the NYVAC genome can be transcribed and translated
correctly in the presence of the replication-competent VVB5R
strain. Next, we sought to determine if under these conditions
actin tail formationwas restored. Cells were infectedwithNYVAC
or VVB5R or coinfected with both viruses (2.5 PFU/cell of each
virus), and the actin cytoskeleton was visualized by phalloidin
staining at 24 hpi. The coinfected cells had characteristic actin tails
(Fig. 2B), indicating the rescue of IEV formation. In contrast, no
actin tails were detected in NYVAC-infected cells or in VVB5R-
infected cells. Moreover, the presence of B5 and A36 proteins in
the coinfected cells was detected with specific antibodies. These
findings suggested that the blockade of viral proteins in NYVAC-
infectedHeLa cells must be associated with a specific translational
inhibitor that remains active during NYVAC infection but whose
activity is blocked in WR-infected cells.
During viral infections, double-strandedRNA (dsRNA) is pro-
duced, which triggers the subsequent induction of type I inter-
feron (IFN). This enhances transcription of genes encoding pro-
tein kinase R (PKR) and the 2=,5=-oligoadenylate synthetase (2-5A
synthetase)/RNase L enzymes, among others (17). Double-
stranded RNA (dsRNA) then binds to and activates PKR and the
2-5A-synthetase, leading to suppression of translation initiation
and to RNA degradation by RNase L, respectively. PKR is also
involved in the regulation of signal transduction, apoptosis, cell
proliferation, and differentiation (17). PKR inhibits viral replica-
tion via phosphorylation of eIF2, which impairs the recycling of
eIF2S1 between successive rounds of translation initiation, lead-
ing to inhibition of this process and eventually to shutdown of
cellular and viral protein synthesis (17, 18). In addition, 2-5A
synthetase produces short, 2=,5=-linked oligoadenylates, which ac-
tivate RNase L, a single-stranded specific endoribonuclease that
degrades mRNA and rRNA, thus controlling major pathogenic
processes (19). We were interested in determining the effects of
PKR and RNase L on NYVAC infection, and in particular, in in-
vestigating whether these proteins were responsible for the abor-
tive replication of NYVAC in HeLa cells.
As we discussed above, in NYVAC-infected HeLa cells the spe-
cific blockage in the translation of viral proteins is accompanied by
eIF2 phosphorylation and apoptosis (2, 3), suggesting that PKR
FIG 1 NYVAC produces an abortive infection in HeLa cells. (A) Viral protein
expression in NYVAC-infected HeLa cells. HeLa cells were mock infected (M)
or infected with WR or NYVAC (5 PFU/cell). At the indicated times postin-
fection, cells were harvested and equal amounts of proteins from cell extracts
were fractionated by SDS-PAGE, transferred to nitrocellulose, and treated
with specific antibodies to early (E3 and A36) and late (B5 and A27) viral
proteins. Actinwas used as a loading control. Themolecularmasses (“MW”; in
kilodaltons) are indicated and were determined based on protein standards.
(B) Blockage in actin tail formation after infection with NYVAC. Mock-in-
fected and WR- or NYVAC-infected HeLa cells (5 PFU/cell) were fixed and
stained using phalloidin coupled to tetramethylrhodamine B isothiocyanate at
24 hpi for actin tail detection. Cells were visualized by confocal immunofluores-
cencemicroscopy.The images showrepresentativefields.Magnification,73. (C)
Cellular extracts from HeLa cells that were mock infected or infected with
NYVAC,MVA, orWRviruses (5 PFU/cell) were collected at 10 hpi into a buffer
containing 1mM sodium orthovanadate. The extracts were analyzed byWest-
ern blotting using the 4G10 monoclonal P-Tyr antibody to detect phosphor-
ylated A36 levels produced after the infection, and results were compared to
those of the total A36. Additionally, A33 expression was determined by West-
ern blotting. The truncated form of A33R after MVA infection is not shown in
the gel. Actin was used as a loading control.
Fernández-Escobar et al.
2136 jvi.asm.org February 2016 Volume 90 Number 4Journal of Virology
could be activated. Taking into account that in response to many
viral infections PKR becomes activated (17), we wanted to test the
role of PKR in the NYVAC replication defect in HeLa cells. HeLa
cells deficient in PKR (HeLa-siPKR) generated by an RNA inter-
ference-silencing strategy and control cells (HeLa-siCTR) were
infected with NYVAC. We then examined viral protein expres-
sion, and although we detected early proteins (E3 and A36) in
both cell types, late proteins were not observed (A27 and B5) in
either PKR-expressing or PKR-deficient cells. Phosphorylation of
eIF2 was, however, observed even in the absence of PKR (Fig.
3A), indicating that PKR is not the activated kinase involved in
this process after NYVAC infection. These results demonstrate
that the inhibition of the translation of viral proteins and viral
replication in NYVAC-infected HeLa cells is independent of PKR
activity (Fig. 3A and B). Since the activation of PKRhas previously
been shown to lead to induction of apoptosis with other VACV
strains (20), andNYVAC induces apoptosis following infection of
HeLa cells, we next assayed the ability of NYVAC to induce apop-
tosis in PKR-deficient HeLa cells. Inspection of HeLa-siCTR and
HeLa-siPKR cells infected with NYVAC by phase-contrast mi-
croscopy showed that both cell lines exhibited morphological
changes characteristic of cells undergoing apoptosis (Fig. 3C). To
confirm our microscope observations, we used an antibody that
recognizes both full-length and cleaved poly(ADP-ribose) poly-
merase 1 (PARP-1) to assess apoptosis in HeLa-siCTR or HeLa-
siPKR cells infected with NYVAC. In both cases, the cleaved
PARP-1 fragment of 89 kDa was evident at 16 hpi (Fig. 3D), indi-
cating thatNYVAC is capable of inducing apoptosis in the absence
of PKR. Similar results were obtained when wemeasured the level
of apoptosis activation with a caspase-Glo 3/7assay kit (Fig. 3E).
These results demonstrated that apoptosis triggered by NYVAC
infection in HeLa cells is not due to PKR activation and, thus,
additional apoptotic routesmust be regulated following infection.
Together, these results indicate that the NYVAC phenotype is dif-
ferent from that observed for the VVE3Lmutant virus that lacks
the viral protein E3, which induces eIF2 phosphorylation and
apoptosis (17) in a PKR-dependent manner (20). Furthermore,
PKR also plays a major role in restricting the attenuated MVA
poxvirus strain (21). This is probably due to the differences be-
tween the genomes of these viruses in encoding inhibitors of the
IFN regulatory pathways (22).
As mentioned before, RNase L is another important enzyme
regulated by IFN that exerts its activity at multiple levels, includ-
ing the degradation of viral and host RNA, as well as induction of
apoptosis (23, 24). Furthermore, host and viral RNAs cleaved by
RNase L function as ligands for RIG-I and MDA5 in amplifying
type I interferon expression and antiviral responses (23, 25). Sev-
eral viruses have mechanisms to directly counteract RNase L ac-
tivity (24). We previously showed that in HeLa cells, NYVAC in-
fection triggers rRNA degradation late in infection, with the same
cleavage pattern observed during activation of the RNase L system
(3). To obtain evidence that RNase L has an effect in NYVAC
replication, we used HeLa cells expressing wild-type RNase L
(HeLa and HeLa-M-W12) or HeLa cells expressing a dominant
negative mutant RNase L (named HeLa-M-M25; kindly provided
by R. H. Silverman).
We first examined rRNA integrity in NYVAC-infected HeLa,
HeLa-M-W12, or HeLa-M-M25 cells. Total RNA was isolated
from infected and mock-infected cells and fractionated by form-
aldehyde-agarose gel electrophoresis. As expected, rRNA degra-
dation was observed in those cells that express parental RNase L
(HeLa andHeLa-M-W12). In contrast, inHeLa-M-M25 cells, that
express a dominant negativemutant RNase L, no breakdown of 28S
and 18S rRNAs was observed after NYVAC infection (Fig. 4A). This
result indicated that the rRNAdegradation after NYVAC infection is
FIG 2 B5R expression and actin tail formation are restored after NYVAC and
VVB5R coinfection. (A) HeLa cells were mock infected (M) or infected with
WR or NYVAC (5 PFU/cell), or coinfected with NYVAC and VVA36R (2.5
PFU/cell per each virus) or NYVAC and VVB5R (2.5 PFU/cell per each
virus). At the indicated times postinfection, equal amounts of proteins from
cell extracts were fractionated by SDS-PAGE, transferred onto nitrocellulose,
and treated with specific antibodies to the B5 late viral protein. Actin was used
as a loading control. Molecular masses (“MW”; in kilodaltons) are indicated
and were determined based on protein standards. (B) Restoration of actin tail
formation after the coinfection with NYVAC and VVB5R. HeLa cells were
mock infected (M) or infected with WR, NYVAC, VVA36R, or VVB5R (5
PFU/cell), or coinfected with NYVAC and VVA36R (2.5 PFU/cell per each
virus) or NYVAC and VVB5R (2.5 PFU/cell per each virus). Actin tails were
stained using phalloidin-tetramethylrhodamine B isothiocyanate at 24 hpi and
visualized by confocal microscopy. Viral proteins B5 and A36 were visualized
using specific antibodies. The images show representative fields. Magnifica-
tion,73.
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FIG 3 Protein synthesis, apoptosis induction, and eIF2 phosphorylation in HeLa-siCTR and HeLa–siPKR cells infected with NYVAC. (A) Viral protein
expression during NYVAC infection. HeLa-siCTR or HeLa-siPKR cells were mock infected (M) or infected with NYVAC (5 PFU/cell). At the indicated times
postinfection, equal amounts of proteins from cell extracts were fractionated by SDS-PAGE, transferred to nitrocellulose, and treated with specific antibodies to
virus early proteins (E3 andA36) and late proteins (B5 andA27). The levels of PKR, eIF2, and phosphorylated eIF2were visualized by using specific antibodies,
and actin was used as a loading control. Molecular masses (“MW”; in kilodaltons) are indicated and were determined based on protein standards. (B) Cells were
infected (0.01 PFU/cell) and at the different times indicated, cells were harvested and virus yieldswere determined by plaque assay. Results represent themeans the
standard deviations of three independent experiments. P values from a two-tailed t test, assuming nonequal variance, were determined. In all cases, we obtained P
values of0.01. (C) Apoptosis induction during NYVAC infection in HeLa cells is a PKR-independent process. HeLa-siCTR or HeLa-siPKR cells were mock
infected (M) or infected with WR or NYVAC (5 PFU/cell). At the indicated times postinfection, apoptosis was assessed via phase-contrast microscopy.
NYVAC-infected cells showed characteristic apoptosis, defined by a rounded, floating, phase-bright, wrinkled shape. (D) Time course of PARP-1 cleavage during
NYVAC infection. HeLa-siCTR or HeLa-siPKR cells were mock infected (M) or infected with NYVAC (5 PFU/cell). At the indicated times postinfection, cells
were harvested and equal amounts of proteins from cell extracts were fractionated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with
antibodies against PARP-1 and against virus early (E3) and late (A27) proteins. An 89-kDa PARP-1 cleavage product was observed at 16 hpi in both cell lines.
Molecular masses (“MW”; in kilodaltons) are indicated and are based on protein standards. PKR levels were visualized using a specific anti-PKR antibody, and
actin was used as a loading control. (E) Quantification of apoptotic cells after NYVAC infection. HeLa-siCTR or HeLa-siPKR cells were mock infected (M) or
infected with NYVAC (5 PFU/cell), and at 6, 16, and 24 hpi, cells were fixed and processed to quantify apoptosis by using a caspase-Glo 3/7 assay kit. Etoposide
and staurosporine treatments were used as apoptosis activators. Results represent the means the standard deviations from three independent experiments. P
values from a two-tailed t test assuming nonequal variance were determined. In all cases, we obtained P values of0.05.
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RNase L dependent. When we examined late (A10 and A27) viral
protein expression in NYVAC-infected HeLa, HeLa-M-W12, or
HeLa-M-M25 cells, we observed total or a nearly complete ab-
sence of these late proteins in cells that express wild-type RNase L.
In contrast, we observed high levels of late viral protein produc-
tion in HeLa-M-M25 cells, indicating that RNase L is involved in
the translational control of late proteins in NYVAC infection (Fig.
4B). Moreover, the presence of late viral proteins correlated with
the capacity of NYVAC to grow in HeLa-M-M25 cells (Fig. 4C).
Finally, we evaluated apoptosis activation inHeLa,HeLa-M-W12,
and HeLa-M-M25 cells infected with NYVAC. PARP-1 cleavage
was considerably decreased after the infection of the HeLa-M-
M25 cells (Fig. 4D). When the apoptosis was quantified by densi-
tometric analysis of the cleaved protein bands, a significant reduc-
tion was observed after infection of the cells that do not express
RNase L, compared with infected HeLa or HeLa-M-W12 cells.
FIG 4 RNA degradation, protein synthesis, virus growth, and apoptosis induction in HeLa, HeLa-M-W12, or HeLa-M-M25 cells infected with NYVAC. (A)
HeLa, HeLa-M-W12, and HeLa-M-M25 cells were mock infected (M) or infected with NYVAC (5 PFU/cell). Total rRNA was isolated from cells uninfected or
infected withNYVAC at 16 hpi; 2g of each sample was applied for electrophoresis, and the gel was stained with ethidium bromide. (B) Viral protein expression
during NYVAC infection. HeLa, HeLa-M-W12, and HeLa-M-M25 cells were mock infected (M) or infected with NYVAC (5 PFU/cell). Cells were harvested at
16 hpi, and equal amounts of proteins from cell extracts were fractionated by SDS-PAGE, transferred to nitrocellulose, and treatedwith specific antibodies to A10
or A27 viral proteins. Actin was used as a loading control. Molecular masses (“MW”; in kilodaltons) are indicated and are based on protein standards. (C) Cells
were infected, and at the different times indicated cells were harvested and virus yields were determined by plaque assay. Results represent the means  the
standard deviations of three independent experiments. P values from a two-tailed t test assuming nonequal variance were determined. In all cases, we obtained
P values of 0.01. (D) PARP-1 cleavage during NYVAC infection. HeLa, HeLa-M-W12, and HeLa-M-M25 cells were mock infected (M) or infected with
NYVAC (5 PFU/cell). At 16 hpi, cells were harvested and equal amounts of proteins from cell extracts were fractionated by SDS-PAGE, transferred to
nitrocellulose, and immunoblotted with anti-PARP-1 antibodies. Numbers appearing under each lane represent the ratio of the intensity of the band corre-
sponding to the PARP-1 cleaved fragments in infected cells to those levels in uninfected cells, as determined by densitometric analysis.Molecularmasses (“MW”;
in kilodaltons) are indicated and are based on protein standards. (E) HeLa, HeLa-M-W12, and HeLa-M-M25 cells were mock infected (M) or infected with
NYVAC-C7L (5 PFU/cell). At 16 hpi, cells were collected and equal amounts of proteins from cell extracts were fractionated by SDS-PAGE, transferred to
nitrocellulose, and treated with specific antibodies to A10 or A27 viral proteins. Actin was used as a loading control. (F) HeLa-M-W12 and HeLa-M-M25 cells
were infected with NYVAC-C7L, and at the different times indicated cells were harvested and virus yields were determined by plaque assay. Results represent the
means the standard deviations of three independent experiments. P values from a two-tailed t test assuming nonequal variance were determined. In all cases,
we obtained P values of0.01.
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While the band corresponding to the cleaved PARP-1 fragment in
infected HeLa-M-M25 cells was 1.9 times more intense than the
same band in mock-infected cells, in infected HeLa and HeLa-M-
W12 cells, this band was 3.8 and 2.8 times more intense with
respect to the corresponding mock-infected cells. This result in-
dicates that the apoptosis induced by NYVAC in HeLa cells is
RNase L dependent. It has been previously demonstrated that the
presence of the viral gene C7L restores the NYVAC capacity to
replicate in HeLa cells at a similar rate as theWR strain (3). Then,
we infected HeLa, HeLa-M-W12, and HeLa-M-M25 cells with a
NYVAC recombinant expressing C7L (named NYVAC-C7L) and
showed that late viral protein production and virus growth were
rescued in HeLa cells expressing wild-type RNase L (Fig. 4E and
F). Lastly, we also measured the viral growth with NYVAC and
NYVAC-C7L in murine embryonic fibroblast (MEFs) from
RNase L/ and RNase L	/	mice, and the results in thesemurine
cells were comparable to those obtained in HeLa cells (data not
shown). As shown here, the replication capacity of NYVAC-C7L
for overcoming the RNase L activity suggests a direct or indirect
role of C7L in blocking RNase L.
In summary, while the poxvirus vaccine candidateNYVAChas
a host-restricted replication phenotype in most human cells, the
mechanism of restriction has remained elusive. In this study, we
showed that after infection of HeLa cells with NYVAC there is a
blockage in the translation of some viral proteins, and that this is
accompanied by an inhibition in the production of actin tails.
Through complementation assays with specific defective viruses,
we showed that the genes encoding late viral proteins are still
capable of being transcribed and translated “in trans” from the
genome of NYVAC, indicating that the viral restriction is related
to cellular factors.We studied two cellular factors with an essential
function in the replication of viruses and pathological processes,
PKR and RNase L. We showed that PKR does not exert a regula-
tory role in NYVAC growth, but RNase L is an essential host re-
striction factor for NYVAC. Since the E3L and K3L genes (26)
involved in RNase L inhibition remain intact in the NYVAC ge-
nome, these results suggest that there are additional viral genes,
such as C7L, that control the action of RNase L.
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